{"id":45933,"date":"2022-07-07T18:02:13","date_gmt":"2022-07-07T16:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-intracranial-hemorrhage-devices-market-to-2027-insights-competitive-landscape-and-forecasts-researchandmarkets-com\/"},"modified":"2022-07-07T18:02:13","modified_gmt":"2022-07-07T16:02:13","slug":"global-intracranial-hemorrhage-devices-market-to-2027-insights-competitive-landscape-and-forecasts-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-intracranial-hemorrhage-devices-market-to-2027-insights-competitive-landscape-and-forecasts-researchandmarkets-com\/","title":{"rendered":"Global Intracranial Hemorrhage Devices Market to 2027 – Insights, Competitive Landscape and Forecasts – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Intracranial Hemorrhage Devices- Market Insights, Competitive Landscape and Market Forecast-2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global intracranial hemorrhage (ICH) devices market was valued at USD 1.59 Billion in 2021, growing at a CAGR of 6.65% during the forecast period from 2022 to 2027 to reach USD 2.35 Billion by 2027.\n<\/p>\n

\nThe increase in demand for Intracranial Hemorrhage (ICH) Devices is primarily attributed to the rising cases of brain disorders such as Stroke, Cerebral\/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices, thereby contributing to the growth of the Intracranial Hemorrhage (ICH) Devices market during the forecast period from 2022-2027.\n<\/p>\n

\nIntracranial Hemorrhage (ICH) Devices Market Dynamics:<\/strong>\n<\/p>\n

\nThe Intracranial Hemorrhage (ICH) Devices market is witnessing a growth in product demand owing to various reasons. The major reason responsible for product demand is due to the rising burden of the patient population suffering from brain disorders such as Stroke, Cerebral\/Brain Aneurysm, Intracranial Stenosis, among others across the globe is expected to fuel the demand for Intracranial hemorrhage (ICH) Devices as these devices are used to treat various conditions and diseases of the brain using minimally invasive neurosurgical techniques.\n<\/p>\n

\nAccording to the World Stroke Organization 2022, globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. 13.7 million people worldwide will have their first stroke each year and five and a half million will die as a result. Also, as per the same statistics, stroke is the leading cause of death and disability globally with 116 Million years of healthy life lost each year to the disease.\n<\/p>\n

\nThus, the rising prevalence of the target population is anticipated to raise the demand for brain surgeries thereby increasing the demand for Intracranial hemorrhage (ICH) Devices during the forecasted period.\n<\/p>\n

\nTherefore, with proper monitoring, these defects can be prevented by undergoing proper care and medication. Hence, the growth of the Intracranial hemorrhage (ICH) Devices Market is expected to rise during the forecast period from 2022 to 2027.\n<\/p>\n

\nHowever, the risk involved with Intracranial Hemorrhage (ICH) Devices and the high cost of equipment and surgeries may be certain limiting factors of the Intracranial Hemorrhage (ICH) Devices market growth.\n<\/p>\n

\nThe market witnessed a COVID-19 outbreak which impacted the use of Intracranial hemorrhage (ICH) Devices. Intracerebral hemorrhage is a very rare but well-documented complication of COVID-19. Stroke has been seen as a manifestation of COVID-19 in various studies showing that 0.9% to 23% of COVID-19 patients developed brain stroke.\n<\/p>\n

\nCompanies Mentioned<\/strong>\n<\/p>\n